A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
Status:
Recruiting
Trial end date:
2028-09-21
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out whether intraperitoneal or intravenous chemotherapy
given after cytoreductive surgery and HIPEC are effective treatments for people with
malignant peritoneal mesothelioma. Outcomes will be compared by observing intraperitoneal
versus intravenous treatments to analyze if one is better than the other.